LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE drug offered from Cadila Healthcare Limited. This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
NON-PROPRIETARY NAME: | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
SUBSTANCE NAME: | HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-04-10 |
END MARKETING DATE: | 0000-00-00 |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE HUMAN PRESCRIPTION DRUG Details:
Item Description | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE from Cadila Healthcare Limited |
LABELER NAME: | Cadila Healthcare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 12.5; 50(mg/1; mg/1) |
START MARKETING DATE: | 2010-04-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65841-732_7d5f5aaf-cf01-4b79-bf35-fe56de1fad1c |
PRODUCT NDC: | 65841-732 |
APPLICATION NUMBER: | ANDA078385 |
Other HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM Pharmaceutical Manufacturers / Labelers: